Baseline demographics and clinical characteristics
| n (%)∗ . | OD group (n = 37) . | RP group (n = 91) . | Total (N = 128) . |
|---|---|---|---|
| Sex, male | 37 (100) | 91 (100) | 128 (100) |
| Age, y | |||
| <18 | 2 (5.4) | 18 (19.8) | 20 (15.6) |
| Mean (SD) | 31.4 (10.54) | 33.0 (14.76) | 32.5 (13.65) |
| Median (range) | 29.0 (15.0-58.0) | 31.0 (13.0-66.0) | 30.0 (13.0-66.0) |
| Hemophilia A | 29 (78.4) | 72 (79.1) | 101 (78.9) |
| Hemophilia B | 8 (21.6) | 19 (20.9) | 27 (21.1) |
| Race | |||
| Asian | 24 (64.9) | 37 (40.7) | 61 (47.7) |
| Black or African American | 0 | 1 (1.1) | 1 (0.8) |
| White | 13 (35.1) | 52 (57.1) | 65 (50.8) |
| Not reported | 0 | 1 (1.1) | 1 (0.8) |
| Ethnicity | |||
| Hispanic or Latino | 4 (10.8) | 9 (9.9) | 13 (10.2) |
| Geographical region | |||
| Asia | 23 (62.2) | 31 (34.1) | 54 (42.2) |
| Europe | 8 (21.6) | 39 (42.9) | 47 (36.7) |
| Middle East | 2 (5.4) | 10 (11.0) | 12 (9.4) |
| North America | 4 (10.8) | 11 (12.1) | 15 (11.7) |
| Mean body mass index (SD), kg/m2 | 23.7 (5.6) | 23.9 (4.2) | 23.8 (4.6) |
| Target joints†at baseline | |||
| 0 | 1 (2.7) | 38 (41.8) | 39 (30.5) |
| 1 | 8 (21.6) | 21 (23.1) | 29 (22.7) |
| 2 | 16 (43.2) | 15 (16.5) | 31 (24.2) |
| ≥3 | 12 (32.4) | 17 (18.7) | 29 (22.7) |
| n (%)∗ . | OD group (n = 37) . | RP group (n = 91) . | Total (N = 128) . |
|---|---|---|---|
| Sex, male | 37 (100) | 91 (100) | 128 (100) |
| Age, y | |||
| <18 | 2 (5.4) | 18 (19.8) | 20 (15.6) |
| Mean (SD) | 31.4 (10.54) | 33.0 (14.76) | 32.5 (13.65) |
| Median (range) | 29.0 (15.0-58.0) | 31.0 (13.0-66.0) | 30.0 (13.0-66.0) |
| Hemophilia A | 29 (78.4) | 72 (79.1) | 101 (78.9) |
| Hemophilia B | 8 (21.6) | 19 (20.9) | 27 (21.1) |
| Race | |||
| Asian | 24 (64.9) | 37 (40.7) | 61 (47.7) |
| Black or African American | 0 | 1 (1.1) | 1 (0.8) |
| White | 13 (35.1) | 52 (57.1) | 65 (50.8) |
| Not reported | 0 | 1 (1.1) | 1 (0.8) |
| Ethnicity | |||
| Hispanic or Latino | 4 (10.8) | 9 (9.9) | 13 (10.2) |
| Geographical region | |||
| Asia | 23 (62.2) | 31 (34.1) | 54 (42.2) |
| Europe | 8 (21.6) | 39 (42.9) | 47 (36.7) |
| Middle East | 2 (5.4) | 10 (11.0) | 12 (9.4) |
| North America | 4 (10.8) | 11 (12.1) | 15 (11.7) |
| Mean body mass index (SD), kg/m2 | 23.7 (5.6) | 23.9 (4.2) | 23.8 (4.6) |
| Target joints†at baseline | |||
| 0 | 1 (2.7) | 38 (41.8) | 39 (30.5) |
| 1 | 8 (21.6) | 21 (23.1) | 29 (22.7) |
| 2 | 16 (43.2) | 15 (16.5) | 31 (24.2) |
| ≥3 | 12 (32.4) | 17 (18.7) | 29 (22.7) |